Yixiao Xing

658 total citations
21 papers, 520 citations indexed

About

Yixiao Xing is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Yixiao Xing has authored 21 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Yixiao Xing's work include Salivary Gland Disorders and Functions (5 papers), Mesenchymal stem cell research (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Yixiao Xing is often cited by papers focused on Salivary Gland Disorders and Functions (5 papers), Mesenchymal stem cell research (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Yixiao Xing collaborates with scholars based in China and United States. Yixiao Xing's co-authors include Xin Xu, Yunpeng Zhang, Linglu Jia, Hong Hua, Yawen Ji, Jing He, Bin Zhao, Yong Wen, Hui Wei and Lu Zhang and has published in prestigious journals such as Endocrinology, Frontiers in Immunology and Gene.

In The Last Decade

Yixiao Xing

18 papers receiving 512 citations

Peers

Yixiao Xing
Comparison fields: 5 of 77
  • Molecular Biology 214
  • Genetics 132
  • Physiology 101
  • Surgery 64
  • Endocrinology, Diabetes and Metabolism 63
Replace Sanja Novak with:
Sanja Novak United States
Yuko Noguchi Japan
Sachiko Ogino Japan
Victor R. Prisk United States
Yugal Behl United States
Xuechun Xia United States
Ningwen Zhu China
Gordana Šupić Serbia
Xue Lin China
Sanja Novak United States View profile →
Citations per field, relative to Yixiao Xing
Yixiao Xing · 1×
Citations per year, relative to Yixiao Xing
Yixiao Xing · 1×

Countries citing papers authored by Yixiao Xing

Since Specialization
Citations

This map shows the geographic impact of Yixiao Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixiao Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixiao Xing more than expected).

Fields of papers citing papers by Yixiao Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixiao Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixiao Xing. The network helps show where Yixiao Xing may publish in the future.

Co-authorship network of co-authors of Yixiao Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Yixiao Xing. A scholar is included among the top collaborators of Yixiao Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixiao Xing. Yixiao Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 0
3 0
4 4
5 42
6 4
7 0
8 66
9 7
10 5
11 14
12 14
13 89
14 33
15 41
16 24
17 86
18 4
19
Expression of calcitonin gene-related peptide (CGRP) mRNA in rat lymphocytes.
2
20 62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026